ArticleObesity surgery2026
Impact of Bariatric Surgery on Reproductive Hormones and Menstrual Regularity in Women with Obesity.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity affects 2.5 billion adults, disrupting the hypothalamic-pituitary-ovarian (HPO) axis through adipokine imbalance and aromatase activity. This causes hormonal dysregulation, infertility, and pregnancy risks. Bariatric surgery can restore hormonal balance and improve menstrual regularity. This study evaluates post-bariatric surgery changes in reproductive hormones and cycle regularity over six months in Egyptian women with obesity.
methodsThis prospective cohort study included women aged 18-45 (BMI ≥ 35 kg/m²) undergoing laparoscopic bariatric surgery. Serum FSH, LH, estradiol, Progesterone, and AMH levels were measured at baseline, 3, and 6 months postoperatively. Secondary outcomes included menstrual regularity and hormonal correlations with weight loss.
resultsBariatric surgery resulted in a highly significant reduction in body weight and BMI over the six-month follow-up period (p < 0.001). Significant hormonal shifts were observed, including increased levels of FSH (p < 0.001) and LH (p = 0.001), a decreased LH/FSH ratio (p = 0.005), and marked reductions in estrogen and progesterone concentrations (p < 0.001). While AMH levels remained stable (p = 0.6), menstrual regularity improved significantly from 20% at baseline to 53.3% post-surgery (p = 0.001). Furthermore, the degree of weight loss was significantly and positively correlated with postoperative FSH and LH levels. The interventions were generally well-tolerated, with 82.4% of participants reporting no postoperative complications. No significant differences in the improvement of weight or hormonal profiles were noted between patients with and without PCOS.
conclusionBariatric surgery induces weight loss and restores reproductive hormonal balance in women with obesity by improving HPO axis regulation. Increased FSH and LH levels, resulting from reduced adiposity, might contribute to improved menstrual regularity. KEY POINTS: • Bariatric surgery resulted in a significant and progressive reduction in body weight and BMI over the six-month follow-up period (p < 0.001). • There was a significant postoperative increase in FSH and LH levels. Estrogen and progesterone concentrations demonstrated significant and sustained reductions post-surgery, whereas AMH levels remained stable throughout the study. • Menstrual regularity improved significantly, increasing from 20% of participants at baseline to 53.3% six months after surgery (p = 0.001). • The degree of weight loss was significantly and positively correlated with postoperative FSH and LH levels.
Indexed as
Identifiers
42842157What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.